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Responses of the central nervous system (CNS) to stressors and injuries, such as ionising radiation, are
modulated by the concomitant responses of the brains innate immune effector cells, microglia. Exposure
to high doses of ionising radiation in brain tissue leads to the expression and release of biochemical
mediators of ‘neuroinﬂammation’, such as pro-inﬂammatory cytokines and reactive oxygen species
(ROS), leading to tissue destruction. Contrastingly, low dose ionising radiation may reduce vulnerability
to subsequent exposure of ionising radiation, largely through the stimulation of adaptive responses, such
as antioxidant defences. These disparate responses may be reﬂective of non-linear differential microglial
activation at low and high doses, manifesting as an anti-inﬂammatory or pro-inﬂammatory functional
state. Biomarkers of pathology in the brain, such as the mitochondrial Translocator Protein 18 kDa
(TSPO), have facilitated in vivo characterisation of microglial activation and ‘neuroinﬂammation’ in many
pathological states of the CNS, though the exact function of TSPO in these responses remains elusive.
Based on the known responsiveness of TSPO expression to a wide range of noxious stimuli, we discuss
TSPO as a potential biomarker of radiation-induced effects.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Contents1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
2. Microglial responses to stressors in the CNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
3. The impact of high dose ionising radiation on the CNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
4. The impact of low dose ionising radiation on the CNS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
5. Mitochondrial Translocator Protein 18 kDa (TSPO) in neuroinﬂammation and responses to ionising radiation. . . . . . . . . . . . . . . . . . . . . . . . . . 150
6. Conclusion and open questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1521. Introduction
The impact of ionising radiation on human physiology has been
documented throughout the last century, subsequent to nuclear
disasters and incidents through inhalation or ingestion of radio-
active material [1]. Aside from environmental exposure, artiﬁcialB.V. This is an open access article
Sciences, Australian Nuclear
llawarra Road, Lucas Heights,
dl@ansto.gov.au (G.-J. Liu).sources of ionising radiation are growing in utility. Currently, ex-
posure to ionising radiation through medical diagnostics and
treatment strategies now constitutes the largest proportion of
average yearly radiation exposure in Australia [2]. The increasing
availability and utility of ionising radiation for medical purposes
warrants a reassessment of the literature on the biological impact
of higher and lower doses of ionising radiation, particularly in
terms of the central nervous system (CNS). Whilst the neurobio-
logical impact of exposure to high dose ionising radiation has been
well documented, the consequences of low dose exposure have
garnered considerable debate [3]. Responses of biological systemsunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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response pattern [4]. Challenge to the prevailing paradigm of a
linear no-threshold model comes in the form of animal radio-
biological data, with several lines of evidence suggesting that ex-
posure to lower doses of ionising radiation may confer neuro-
protection [5–8]. This response has been conceptualised as radia-
tion hormesis, where exposure to a stressor in low amounts can
induce protective, radioadaptive and reparative mechanisms
[9,10], though this is not without contention. Insufﬁcient data
expounding the beneﬁcial effects of low dose ionising radiation on
human physiology, and a lack of consensus regarding the deﬁni-
tion of ‘low dose’, has meant that the concept of radiation horm-
esis is not currently acknowledged by international panels and
governing bodies. Though there is still uncertainty surrounding
the nature of biological responses to high and low dose ionising
radiation, a more comprehensive understanding of the molecular
and cellular processes underlying radiobiological responses is
currently evolving [11], particularly within the context of the
complex and multifaceted CNS.
Since its early discovery, radiation science has expanded in
utility to medical practices [12–14], though it was not until later in
history that the effects of ionising radiation on the brain were
directly examined [15]. The paradox of utilising ionising radiation
for therapeutic and medical diagnostic purposes is that at higher
doses it may induce damage to normal tissue. The non-cancer
effects of ionising radiation exposure, and the cellular reactions it
can produce in the adult CNS, will be the focus of this review. In
the literature, one of the more prominent manifestations of ra-
diation-induced injury is seen in the hippocampus, a radio-
sensitive region housing populations of proliferating progenitor
cells [16–18]. High dose irradiation can induce dysfunction or
apoptosis to mature or newly born differentiating cells that in-
tegrate into the hippocampal network, manifesting as longer term
functional deﬁcits [19]. Orchestrating responses to high dose ir-
radiation are microglial-mediated neuroinﬂammation and oxida-
tive stress induced by excess reactive oxygen species (ROS) for-
mation [20,21]. Mitochondrial redox balance and microglial re-
sponses are also critical in modulating responses to low dose ir-
radiation, largely through the stimulation of antioxidant defences
[7]. Whilst some evidence still points to a linear dose-response
pattern, there is signiﬁcant evidence to suggest that lower doses
can confer protection to cell functioning, molecular structures,
synapses, and key brain mechanisms such as neurogenesis, and
induce reparative mechanisms in the face of CNS pathology
[10,22]. Based on guidelines by regulatory bodies, as well as data
generated by low dose radiation research programs, a low dose is
considered to be acute exposure to less than 100mSv, or 0.1 Gy
[23,24]. Rather than adopting a stringent demarcation between
‘high’ and ‘low’ doses of ionising radiation, we will discuss ‘low
dose’ data within the broader range of doses up to 1 Gy, a deﬁni-
tion which extends across many radiobiological studies.
Here we review the literature regarding the impact of ionising
radiation on the CNS, highlighting remaining uncertainties sur-
rounding the disparate responses to high and low doses of ionising
radiation that are underscored by mitochondrial redox balance
and neuroinﬂammation. This review aims to synthesise the im-
portant aspects of CNS functionality under conditions of stress,
injury and pathology, which can elucidate the neurobiological
responses to ionising radiation at different doses. In order to en-
hance understanding in this ﬁeld and dissect the subcellular and
molecular events that drive radiation-induced neurobiological
responses, a key biomarker of CNS pathology, the mitochondrial
Translocator Protein 18 kDa (TSPO), will be examined. We in-
troduce TSPO as a novel perspective in clarifying the responses of
the CNS to ionising radiation, and highlight its centrality to a
comprehensive understanding of the complex network linkingneuroinﬂammation and mitochondrial redox balance. Its utility as
a sensitive in vivo biomarker of microglial activation, coordinating
the brains innate immune response, may lead to new insights into
how this process may modulate CNS responses after high and low
dose irradiation, as well as elucidating the exact function of this
enigmatic protein.2. Microglial responses to stressors in the CNS
The coordination of responses to insults and stressors in the
CNS are complex and multifaceted. Neurobiological mechanisms
of inﬂammation, protection, defence and repair comprise of net-
works of cells and molecular mediators that respond to alterations
in homeostasis [25]. Neuroinﬂammation is inherent to an under-
standing of CNS responses after such alterations, for example ex-
posure to ionising radiation. This mechanism is distinctively
characterised by the presence of activated microglia, the brains
innate immune effector cells, which exhibit striking morphological
and functional plasticity in response to insults [26,27]. In their
resting state, microglia display highly ramiﬁed morphology and
survey the microenvironment, though in the presence of en-
dogenous or exogenous stressors, these cells can proliferate and
transition morphologically to an amoeboid, activated state [28–
30]. Activated microglia initiate an inﬂammatory response by re-
leasing pro-inﬂammatory factors including cytokines and ROS
[20,31]. The pro-inﬂammatory state of activated microglia, or the
M1 type classical activation state, can be cytotoxic to surrounding
cells, and when unregulated can propagate tissue damage and
cause secondary injury [32,33]. Correspondingly, neuroinﬂamma-
tion is thought to be implicated in multifarious functions and
pathological states in the CNS, including the modulation of neu-
rogenesis and neuronal development [25,34,35], synaptic strip-
ping and neuronal dysfunction [36,37], and is now widely im-
plicated in the pathogenesis and progression of many neurode-
generative disorders [38–45]. Alternatively, an M2 microglial ac-
tivation state is not neurotoxic, transiently conferring neuropro-
tection and anti-inﬂammatory properties in response to injury
[46]. Microglial M2 activation and M2-derived factors have been
demonstrated to promote remyelination and activate reparative
and regenerative growth responses after lesions [47]. This activa-
tion state can also down-regulate inﬂammation, and reduces
secondary injury which may be induced by inﬂammation [48],
though the shift between M2 and M1 phenotypes is not well un-
derstood. The polarised activation states of microglia may also be
implicated in the responses of the brain to ionising radiation, and
furthermore, the disparate activation states may be reﬂective of
the anti-inﬂammatory or pro-inﬂammatory responses of microglia
after low and high dose ionising radiation, a topic which warrants
future investigation.
Importantly, classically activated M1 microglia and its asso-
ciated pro-inﬂammatory functions are intrinsically linked to the
production of free radicals [20,26,49]. The production of ATP
through oxidative phosphorylation results in the formation of
oxidant by-products which can be damaging to cell components in
sufﬁcient quantities. The inability of antioxidant compounds and
enzymes to neutralise the adverse effects of excess ROS con-
tributes to oxidative stress, which can manifest as damage to nu-
cleic acids, protein degradation, and lipid peroxidation in cells
[50]. Concomitantly, reactive nitrogen species (RNS) and nitric
oxide (NO) can also coordinate microglial responses to stressors in
the CNS [51–53]. Activated microglia have also been shown to
produce excess ROS and H2O2 from NADPH oxidases, which also
generate large amounts of oxidants in activated phagocytic cells
[54] and are important to the progression of ROS-mediated neu-
roinﬂammatory collateral damage to surrounding cell populations
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isms such as the NF-κB pathway to release ROS, RNS and pro-in-
ﬂammatory cytokines such as TNF-α, IL-1β and IL-6, or through
MAPK signalling pathways that activate NADPH to coordinate
neuroinﬂammation [20,51,57–60]. Indeed, neuroinﬂammation and
oxidative stress have been implicated in several CNS disorders,
notably Alzheimer’s disease [61,62] and Parkinson's Disease
[40,57,63], potentiating cellular damage and pathology. The bal-
ance between oxidants and antioxidants is also fundamental to the
normal physiological functioning of the CNS [64], as antioxidant
processes have been shown to alleviate oxidative stress-induced
damage and inﬂammatory responses by activated microglia
[62,65,66]. Together, the aforementioned mechanisms are also
critical in modulating responses of the irradiated CNS, and an
understanding of the machinery behind neuroinﬂammation and
redox balance can therefore help elucidate the responses of the
CNS to ionising radiation at different doses.3. The impact of high dose ionising radiation on the CNS
One of the earliest physiological responses to ionising radiation
is the production of ROS [67], which can induce oxidative stress
and neuroinﬂammatory processes at sufﬁciently high doses of
ionising radiation. A recent meta-analysis of published data sug-
gests an overall signiﬁcant effect of oxidative damage in response
to ionising radiation, particularly on cells of the brain. Interest-
ingly, there was signiﬁcant heterogeneity in effect sizes among
species and cell types across the body [68], highlighting the large
variability of responses to ionising radiation. Indeed, even within
the CNS, the complex interrelationships between neuroin-
ﬂammatory responses, mitochondrial redox mechanisms and dif-
ferent cell populations complicate the understanding of responses
to ionising radiation at different doses [24]. It is clear, however,
that ionising radiation can impact nucleic acids [69,70],Fig. 1. Publications trends using the SCOPUS database. ‘Ionising radiation’ and ‘microgli
The lack of research between 1964 and 1997 is signiﬁcant, and the striking increase in
‘neuroinﬂammation’ as a proliﬁc research ﬁeld within neuroscience. Even fewer results a
included (6), representing the paucity of studies on this topic. The second wave of publ
1970s may be as a result of the heightened use of medical radiation technologies and tneurovascular permeability [71–73], induce ROS/RNS [21,67,74,75]
and elicit a neuroinﬂammatory response [76–78], all of which can
manifest as radiation-induced injury.
The presence of cognitive decline in patients after clinical ex-
posure to high dose irradiation has led to a research focus on the
hippocampal microenvironment and its population of mature cells
and proliferating progenitor cells in the subgranular zone of the
dentate gyrus. This region of neurogenesis is particularly sensitive
to ionising radiation [79], as mitotic cells are radiosensitive at
stages of the cell cycle between the G2 and M phase [80–83].
Doses of ionising radiation above 1 Gy can inﬂuence neural pro-
genitor cell survival in the hippocampus by signiﬁcantly reducing
the number of newly differentiated cells, increasing DNA damage
( γ-H2AX nuclear foci), promoting cell-cycle arrest, and inducing
oxidative/nitrosative stress, which ultimately implicates the
functionality of the hippocampus manifesting as cognitive im-
pairment [84–88]. Cell viability and apoptosis are important im-
plications of high dose irradiation across the cell populations of
the CNS, as gamma irradiation at 10 Gy in cell cultures reduces cell
survival and increases apoptosis through the up-regulation of key
apoptotic proteins, including cytochrome-c, caspase-3 and de-
creased expression of anti-apoptotic Bcl-2. Concomitantly, ele-
vated pro-inﬂammatory cytokines TNF-α, IL-1β and IL-6 and lipid
peroxidation markers relative to sham irradiated controls also
highlights critical inﬂammatory responses after high dose ionising
radiation that can propagate radiation-induced injury [89].
A search using the SCOPUS database for ‘ionising radiation’ and
‘microglia’ yields a steady increase in publication numbers since
the earliest recorded data by Estable-Puig et al. in 1964 (refer to
Fig. 1). Such was the ﬁrst demonstration of cortical microglial ac-
tivation, as well as the degeneration of myelin, in response to high
dose particle irradiation [15]. It is now recognised that sufﬁcient
doses of ionising radiation can induce microglial activation and
pro-inﬂammatory derived factors which can propagate radiation-
induced brain injury [90,91]. Correspondingly, radiation-induceda’ yields fewer results (49) than ‘ionising radiation’ and ‘brain’ search terms (2330).
literature in the last 2 decades may coincide with the emergence of the concept of
re yielded for ‘low dose ionising radiation’ (328), and fewer yet when ‘microglia’ is
ications on ‘low dose ionising radiation’ and ‘brain’ starting at the beginning of the
he consequent clinical exposure of patients to low doses.
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campus [92–95], with longer term cognitive deﬁcits in patients
persisting from months to decades after initial exposure [96]. In-
terestingly, the ﬁnding of reversible inhibition of the proliferative
capacity of progenitor cells in the dentate gyrus 1 week after 4 Gy
X-radiation exposure, with an absence of microglial activation
[97], suggests there is a requirement of neuroinﬂammatory pro-
cesses to cause persistent and deleterious effects to cells [98]. In
the important work of Monje et al. (2003), 10 Gy X-irradiation in
adult mice incites microglial activation in the hippocampus,
causing signiﬁcant reductions in the proliferative capacity of pro-
genitor cells, impacting cell fate. This neuroinﬂammatory response
was alleviated during and after irradiation with application of an
anti-inﬂammatory agent, partially restoring the proliferative ca-
pacity of these cells [98]. Activated microglia can inhibit neuro-
genesis after higher doses of ionising radiation through the release
of pro-inﬂammatory cytokines IL-1β, TNF-α and IL-6, also con-
tributing to progenitor cell dysfunction [84,98–101]. Importantly,
the pro-inﬂammatory reactions of microglia subsequent to high
dose irradiation typify the M1 microglial activation state, as op-
posed to M2 phenotypye [102]. The pro-inﬂammatory micro-
environment after irradiation may also develop as a result of dis-
ruption to the blood brain barrier [103,104] (as illustrated in
Fig. 2). Doses above 5 Gy can promote apoptosis of endothelial
cells in the brain, thereby causing microvascular damage, as well
as contributing to radiation-induced cognitive dysfunction [105].
Compromise of the blood brain barrier can result in increases of
peripherally derived macrophages [99], or brain inﬁltrating leu-
kocytes, expressing factors such as CCR2 or ICAM-1 [106]. Radia-
tion also increases vulnerability of the brains microvasculature and
perivascular cells, which can lead to increased DNA damage and
premature senescence in surviving cells [73].
The induction of pro-inﬂammatory factors can occur through
pronounced activation of transcription factors such as NF-κb,
causing aberrant regulation of genes involved in pathological in-
ﬂammatory states [91,107,108], and can also induce apoptosis
[67,109]. Correspondingly, Schnegg et al. [108] applied the anti-
inﬂammatory and antioxidant PPARδ agonist to BV-2 microglial
cell cultures prior to a single dose of 10 Gy gamma radiation. This
agent alleviated radiation-induced neuroinﬂammation byFig. 2. Radiation exposure compromises the integrity of the blood-brain barrier (BBB). A
peripheral immune system represents an intact BBB. Compartmental separation may no
can induce damage and apoptosis of endothelial cells, resulting in the inﬁltration of p
partmental separation between the CNS and the peripheral immune system. High doses
immune response.reducing TNF-α, IL-1β and COX-2 expression via NF-κB, whilst also
inhibiting ROS generation, revealing the critical importance of ROS
modulation in neuroinﬂammatory responses after high dose io-
nising radiation. PPARδ activation also inhibited phosphorylation
of c-Jun and MEK/ERK1/2 which regulated the inhibition of ROS
formation and the expression of pro-inﬂammatory factors [108]. A
congruous effect has also been demonstrated utilising other clas-
ses of PPAR agonists, adding to the signiﬁcance of these mechan-
isms in the reactions of microglia following high dose irradiation
[110]. Analogously, Deng et al. (2012) demonstrated the im-
portance of the MAPK MEK/ERK1/2 signalling cascade in mediat-
ing the responses of microglia after high dose irradiation. Ex-
posure of BV-2 microglial cell cultures to 10 Gy gamma radiation
induced the phosphorylation of c-Jun and ERK1/2, which corre-
lated with increases in the expression of pro-inﬂammatory factors
and ROS. Application of NADPH oxidase inhibitors resulted in a
marked reduction in ROS after irradiation and decreased c-Jun
phosphorylation, indicating that radiation-induced oxidative
stress stimulates MEK/ERK1/2 signalling cascade to activate c-Jun,
inciting a neuroinﬂammatory response in microglial cells [49].
Oxidative stress and redox balance play critical roles in the
responses of cells to higher doses of ionising radiation [21,95,111].
Acute increases in mitochondrial ROS/RNS generation at a dose-
dependent rate from 1 to 10 Gy, accompanied by changes in mi-
tochondrial membrane potential, and mitochondrial permeability,
characterise one of the most widely observed cellular reactions to
ionising radiation [112]. Acute increases in lipid peroxidation after
exposure to doses above 2 Gy, measured as a function of mal-
ondialdehyde (MDA) levels in brain tissue, can persist months
after exposure [113], signifying sustained oxidative stress-induced
injury. Accompanying increases in oxidative stress are increases in
deleterious DNA damage such as double strand breaks (DSBs) and
decreases in DNA repair proteins, which in turn can lead to
apoptosis via cell-cycle arrest pathways and even reductions in
cortical thickness [114]. Oxidative stress mediated damage in the
brain can also occur as a result of diminished antioxidant enzyme
activity such as superoxide dismutases (SOD), glutathione and
catalase after irradiation above 2 Gy, which typically counteract
the deleterious effects of ROS accumulation in cells [115]. The
importance of antioxidant defences is highlighted by the ﬁnding ofdapted from [146,147]. (A) Normal compartmental separation of the CNS from the
t be compromised following low dose radiation exposure. (B) High dose irradiation
eripheral macrophages (as indicated by red arrows), disturbing the normal com-
can also induce microglial activation (cells in red), responsible for the brains innate
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C. Betlazar et al. / Redox Biology 9 (2016) 144–156148linear decreases from 2 to 5 Gy in the activity of Cu/Zn/Mn-SOD in
both the hippocampus and the cortex up to 24 h post-exposure.
The hippocampus displayed more signiﬁcant decreases in anti-
oxidant activity, highlighting the greater sensitivity and impaired
recovery capacity of this region [80]. More recently, Ismail et al.
[113] demonstrated that after a single dose of 6 Gy gamma radia-
tion in rodents, there were signiﬁcant increases in DNA DSBs, in-
creased levels of lipid peroxidation, with a concomitant reduction
in glutathione and SOD activity compared to sham irradiated
controls. These responses were ameliorated in the group pre-
treated with an antioxidant agent, demonstrating the importance
of antioxidative neutralisation of oxidative stress-induced injury
after high dose irradiation [113]. Interestingly, the integral im-
portance of antioxidants has been highlighted in studies utilising
mitochondrial catalase overexpression. This overexpression neu-
tralises lipid peroxidation in the hippocampal region after ex-
posure to doses above 2 Gy [116], as well as preserving neuronal
and dendritic networks in the hippocampus, ultimately decreasing
radiation-induced cognitive dysfunction [117].
Though there are inconsistencies in the dosages, dose rates,
radiation sources (refer to Table 1) and in vitro and in vivo meth-
odologies used in studies, it is apparent that responses of the CNS
to higher doses of ionising radiation are underscored by excess
ROS production, contributing to oxidative stress related damage
and neuroinﬂammation. It is interesting to note that many of the
studies examined here, and indeed throughout the literature in
general, apply a single dose irradiation to tissue and examine the
effects thereafter (as highlighted in Table 1), which may not be
predictive of outcomes after other dosing schedules. Greene-
Schloesser et al. (2010) demonstrated that in the hippocampal
dentate gyrus, there was greater activation and proliferation of
microglia after single dose exposure compared to corresponding
fractionated doses delivered in 5 Gy fractions twice a week for 2–4
weeks. This serves to highlight the differences in cell responses to
dose fractions as compared with administration of a single acute
dose [118], and in particular, may highlight the sensitivity of mi-
croglial reactivity to the acuteness of the stressor that is delivered
to the brain.Ta
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e4. The impact of low dose ionising radiation on the CNS
A large amount of uncertainty remains concerning the impact
of low dose ionising radiation on the CNS. Additionally, there is a
lack of consensus regarding the deﬁnitions of ‘low dose’ ionising
radiation, in terms of both total dose and dose rates. An ex-
amination of publication trends reveals a relative decrease in the
literature regarding low dose ionising radiation and the brain as
compared to higher doses, emphasising the lack of uncertainty
surrounding the neurobiological effects of low doses (see Fig. 1). Of
the earliest research into acute low dose effects on the adult brain,
Yamaoka et al. [119] provided demonstrable evidence of the acti-
vation of protective mechanisms in the brain, through the induc-
tion of antioxidant activity that mitigates lipid peroxides [119].
Though there is still contention surrounding the nature of re-
sponses to low dose irradiation, a prevalent theme in much of the
literature indicates that low dose irradiation may not induce de-
leterious alterations in cognition, cell functioning, DNA and gene
expression, apoptosis, nor pathological signs in vivo [120], and that
it may in fact stimulate molecular and cellular protective me-
chanisms [8].
Moreover, where higher doses may incite a neuroinﬂammatory
response, lower doses of gamma radiation at 0.5 Gy have been
shown to attenuate inﬂammatory responses by suppressing the
release of pro-inﬂammatory cytokines. Interestingly, the striking
lack of publications regarding ‘low dose ionising radiation’ and
C. Betlazar et al. / Redox Biology 9 (2016) 144–156 149‘microglia’ from the SCOPUS database (refer to Fig. 1) highlights
the relative quiescence of data on this topic. Though there is a
paucity of literature directly measuring the responses of microglia
to low dose irradiation, there is evidence of decreased neuroin-
ﬂammation with concomitant suppression of ROS-mediated da-
mage and apoptosis. Low dose irradiation of hippocampal neurons
at 0.2 Gy has been demonstrated to enhance cell viability through
the suppression of ROS 5 days post-exposure, compared to higher
doses of 2 Gy which compromised cell survival [121]. Similarly,
human neural stem cell cultures irradiated with charged particles
at 0.05–0.25 Gy showed increased levels of ATP, and decreased
ROS/RNS levels, which contributed to increased cell survival, as
opposed to cells irradiated at higher doses of 1 Gy [122]. Thus, low
dose ionising radiation may stimulate defences against neuroin-
ﬂammation and attenuate oxidative stress, which crucially inﬂu-
ences cell proliferation, cell functioning and ultimately cell survi-
val in the CNS. Radioadaptive dosing, where cells are pre-primed
with a low dose, can reduce vulnerability to subsequent exposure
to higher doses, also producing a neuroprotective effect. Otsuka
et al. [123] demonstrated that animals primed with pre-exposure
to doses of 0.5 Gy gamma radiation developed increased resistance
to DNA damage after subsequent exposure to a higher challenge
dose of 1.6 Gy, compared to mice irradiated with the higher dose
alone [123], indicative of a radioadaptive response [22,124]. In
terms of inﬂammation, decreases in pro-inﬂammatory markers in
the mouse hippocampus and cortex were present only in animals
primed with a 0.1 Gy dose prior to subsequent exposure to 2 Gy,
suggesting that early exposure to low doses can prevent the up-
regulation of inﬂammation by higher doses [100]. Though radio-
adaptive responses have been demonstrated in different cell types,
further exploration into the radioadaptive dosing paradigm in
terms of its effects on the brains innate immune system is needed.
Importantly, evidence suggests that the responses of DNA and
gene expression in the CNS after low doses of ionising radiation
are qualitatively different from higher dose exposures. Important
work from Yin et al. [125] demonstrated that 0.1 Gy gamma ra-
diation can induce alterations in gene expression involved in
neuroprotective functions, notably DNA repair, cell-cycle control,
lipid metabolism and stress responses. Interestingly, late changes
implicated genes involved in metabolic functions, myelin and
protein synthesis and increases in transcripts for antioxidative
enzymes [125]. Analysis of transcriptome proﬁles after low dose
irradiation of 0.1 Gy has also demonstrated the acute alterations in
expression levels of genes involved in damage responses, signal-
ling pathways associated with cognition, and the downregulation
of ERK/MAPK, which are signiﬁcantly different to pathways in-
duced by 2 Gy [126]. The importance of dose delivery schedules
must also be highlighted, as protracted exposure to 0.05 Gy X-rays
over 10 days alters molecular signalling pathways in the hippo-
campus and cortex, such as the expression and phosphorylation of
protein kinases ERK1/2 and AKT, as well as decreasing hippo-
campal cell proliferation. These alterations were not present after
administration of a corresponding single dose of 0.5 Gy [127],
demonstrating that continuous exposure resulted in a more pro-
nounced, deleterious effect. The striking incongruence in results as
a function of altering the dose delivery method thus limits the
ability of single acute doses to predict outcomes to continuous or
protracted exposure.
In rodent models of neuropathology, low dose ionising radia-
tion exposure has been shown to confer neuroprotection and ac-
tivate reparative mechanisms. Kojima et al. (1998) utilised a
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of
Parkinson’s Disease to demonstrate acute increases in the levels of
glutathione and catalase 3 h after exposure to a single dose of
0.5 Gy gamma radiation, with concomitant neutralisation of lipid
peroxidation [128]. This has been conﬁrmed more recently in amouse model of Parkinson’s Disease after whole body gamma
radiation at 1.5 Gy, where irradiated diseased animals had de-
monstrable restoration of glutathione levels, and even elevated
levels of striatal dopamine [129]. Such neuroprotective effects
after exposure to the slightly higher dose of 1.5 Gy also serves to
highlight the ambiguity surrounding the exact parameters of high
and low doses. Higher doses of ionising radiation were once used
therapeutically for lymphoid radiation to treat Multiple Sclerosis,
though not without contention [130–132]. More recently, in ex-
perimental models of Multiple Sclerosis, low dose gamma radia-
tion delivered at repeated doses of 0.5 Gy attenuated experimental
autoimmune encephalomyelitis (EAE) though suppression of pro-
inﬂammatory factors such as TNF-α, IL-6, cytotoxic T cells, and
induced recruitment of regulatory T-cells, which are involved in
the therapeutic effect [133,134]. This anti-inﬂammatory effect has
also been demonstrated in genetic autoimmune disease models in
mice, where after 5 weeks of continuous 0.35 mGy/h and 1.2 mGy/
h gamma irradiation, treated mice had attenuated cerebral in-
ﬂammation, and increases in lifespan comparative to non-irra-
diated controls, indicating a persistent protective effect of low
dose irradiation [135]. In animal models of brain injury and tissue
damage, radon inhalation at 2000 Bq/m3 for 24 h mitigated neu-
ronal injury in the hippocampus whilst also stimulating acute
increases in the activity of SOD and glutathione levels compared to
controls [136]. Comparable responses have been demonstrated
after single dose 0.5 Gy X-irradiation, which can also elevate an-
tioxidant levels in the presence of lesions, rescuing cells from
apoptosis, relative to sham irradiated controls [137]. Interestingly,
Otani et al. [138] demonstrated analogous ﬁndings in a neurode-
generative model of retinitis pigmentosa, where cranial exposure
to 0.65 Gy gamma radiation in diseased mice rescued photo-
receptor cells from apoptosis, increased cell survival, and pre-
vented further degeneration compared to mice exposed to 2 Gy.
Remarkably, Prdx2 antioxidative gene upregulation was observed
after this low dose exposure, with silencing of this gene causing
the rescue effect to be lost [138].
Antioxidative mechanisms are evidently implicated in the
neuroprotective and reparative responses that low dose ionising
radiation can confer [139]. Interestingly, in studies of medical
professionals and hospital staff, blood antioxidant levels were
signiﬁcantly higher in participants exposed to low dose ionising
radiation ranging from 0.1 to 3.8 mGy per month compared to
unexposed controls [140,141], though the paucity of literature on
human studies necessitates further investigation of this effect. In
mice, whole body exposure to both 0.1 Gy and 1 Gy gamma ra-
diation boosts levels of glutathione, catalase and SOD activity in
brain tissue after 2 weeks, but returns to baseline at 4 weeks [142].
Corroborating evidence from Veeraraghavan et al. [143] demon-
strated that after single dose exposures to 0.1 or 0.5 Gy gamma
radiation in mice, increases in the gene expression of SOD2 and
SOD activity facilitated through the NF-κB and SOD signalling
network persisted 8 days after exposure. Notably, antioxidant
upregulation was not present after exposure to 0.02 Gy, suggesting
that the mitochondrial machinery behind this response requires
sufﬁcient exogenous stimulation by low dose ionising radiation
[143]. More recent evidence from Abdel-Rafei et al. [144] high-
lighting the importance of mitochondrial redox balance to low
dose responses demonstrates that exposure to fractionated 0.5 Gy
(twice 0.25 Gy at 2 d interval) gamma irradiation prior to bio-
chemical insult can ameliorate lipid peroxidation and produce an
anti-apoptotic effect in the hippocampus, whilst also increasing
levels of glutathione, SOD and catalase activity in this region.
Importantly, such responses also manifested as signiﬁcant im-
provements in cognitive functioning [144].
There is a growing body of evidence to suggest that low dose
ionising radiation exposure to the CNS produces responses that are
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C. Betlazar et al. / Redox Biology 9 (2016) 144–156150consistent with the radiation hormesis model, though incon-
sistencies in the literature emphasise the need for further research
in this ﬁeld. Recently, Katsura et al. [145] irradiated human neural
progenitor cell cultures with low dose gamma radiation at 3 very
low doses rates corresponding to 0.031–0.496 Gy delivered con-
tinuously for 72 hours. Demonstrable dose-dependent alterations
in DNA DSBs, increases in inﬂammatory markers, cell-cycle arrest
and increased gene expression of apoptotic pathways ultimately
impacted cell differentiation and survival [145]. These ﬁndings
emphasise the importance of dose rate as well as total dose (refer
to Table 2), schedule of delivery, and in vivo and in vitro metho-
dology, all of which are varied across the majority of studies. Dose
fractionation, protraction or acute single dose delivery can all
manifest different neurobiological outcomes, from the molecular
to the cellular level, which needs to be considered in future stu-
dies. Despite the heterogeneity in experimental conditions
throughout the literature, it is clear that a salient trend across the
radiobiological data points to a protective and adaptive effect of
low dose ionising radiation. In order to further characterise CNS
responses to low dose irradiation, and address the remaining
uncertainties, a direct examination of microglial responses, as well
as the machinery driving antioxidant stimulation, will need to be
determined. The potential induction of an M2 microglial activation
state following low dose irradiation, which can down-regulate
inﬂammatory responses and induce reparative mechanisms in
response to injury, should also be explored in future studies. This
may also delineate the phenotypes of microglia in response to
varying stimuli in the CNS.Ta
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st5. Mitochondrial Translocator Protein 18 kDa (TSPO) in neu-
roinﬂammation and responses to ionising radiation
An understanding of the mitochondrial mechanisms that drive
oxidant/antioxidant production and microglial activation after ir-
radiation remains elusive. Given the remaining uncertainties sur-
rounding the susceptibility of the CNS to ionising radiation at
different doses, new research modalities and approaches to the
study of mitochondrial biology are needed. Enhanced under-
standing of the interdependence between mitochondrial me-
chanisms and neuroinﬂammation has been facilitated through
sensitive in vivo neuroimaging markers, such as the mitochondrial
Translocator Protein 18 kDa (TSPO), which has garnered con-
siderable attention [148,149]. Though its exact role in cellular
functioning remains elusive, TSPO has been regarded as integral to
cholesterol transport and steroid hormone synthesis, consistent
with its nomenclature [150]. However, the creation of a viable
TSPO knockout mouse model by Banati et al. [151] has challenged
this function, indicating that the role of TSPO lies beyond ster-
oidogenesis and cholesterol translocation [151,152]. The TSPO
knockout mouse model will facilitate further studies into the role
of this outer mitochondrial membrane protein in cellular func-
tioning [152], where it is hoped that further studies will provide a
novel perspective for TSPO in responses after ionising radiation.
Interestingly, in the CNS, TSPO expression is quiescent under
normal physiological conditions, yet is predominantly, if not ex-
clusively, upregulated in activated microglia under conditions of
stress or pathology [153–156]. This has spurned proliﬁc in-
vestigations into its utility as a biomarker of neuroinﬂammation
[146,157]. It should be noted that perivascular cells and en-
dothelial cells too express binding sites for TSPO ligands [158],
though the TSPO regulation in this compartment has not yet been
fully investigated. Speciﬁc ligands and the use of in vivo neuroi-
maging techniques such as Positron Emission Tomography (PET)
have implicated TSPO in multifarious disease states of the nervous
system, including neurodegenerative disorders [159–162],
Fig. 3. Ionising radiation and the cellular and molecular mediators of responses in the CNS. (A) Low dose ionising radiation may confer neuroprotection by decreasing
neuroinﬂammation, increasing antioxidant levels and neutralising oxidative stress. (B) High dose ionising radiation provokes a neuroinﬂammatory response via activated
microglia (cells in red), pro-inﬂammatory cytokines and reactive oxygen species (ROS) which can have deleterious effects on cell functioning and survival. The role of TSPO in
modulating ROS may also implicate this protein in redox balance after ionising radiation at different doses. Adapted from [146,147].
C. Betlazar et al. / Redox Biology 9 (2016) 144–156 151dementia [163], amyotrophic lateral sclerosis [164,165], multiple
sclerosis [158,166,167] and brain tumours [168,169]. In experi-
mental models, ligands of TSPO such as PK11195 have been found
to reduce pro-inﬂammatory gene expression of COX-2, TNF-α and
IL-6 after stimulation with lipopolysaccharide (LPS) [170,171], with
a concomitant reduction in the number of activated microglia,
sparing further degeneration [172]. Thus, TSPO is now the target of
research into high afﬁnity therapeutic ligands against various
pathologies of the CNS [173].
Functional characterisation of this protein within mitochondria
remains elusive. Furthermore, the mechanisms by which TSPO
contributes to microglial activation remains a topic of great in-
terest, and enhanced understanding may be useful for uncovering
novel insights into responses after ionising radiation exposure.
Currently, TSPO deletion in mice has uncovered the role of TSPO in
mitochondrial bioenergetics, as TSPO deﬁcient mice display sig-
niﬁcant decreases in oxygen consumption [174], and produce
signiﬁcantly less ATP in microglial cell cultures compared to
wildtype mice [151]. As the production of mitochondrial ROS is
intrinsically linked to ATP production, TSPO has also been im-
plicated in the regulation and production of ROS, and ultimately,
ROS-mediated oxidative damage and apoptosis [175]. Veenman
et al. (2010) demonstrated that activation of TSPO facilitates ROS
generation and ATP depletion, with involvement of the mi-
tochondrial FoF1-ATP(synth)ase, leading to the activation of cas-
pase-3, collapse of mitochondrial membrane potential, and the
induction of apoptosis [176,177]. Indeed, several lines of evidence
demonstrate an intrinsic role of TSPO in ROS generation, which
ultimately impacts cell viability and survival. TSPO can up-regulate
the production of ROS in complex with the voltage-dependent
anion channel (VDAC1) of the outer mitochondrial membrane, as
overexpression of the protein is associated with increased oxida-
tive stress [178] and involvement in apoptotic pathways [179]. Lin
et al. [180] demonstrated that inactivation of the Tspo homolog in
Drosophila decreased caspase 3/7 activity and inhibited apoptosis
triggered by 30 Gy gamma radiation and H2O2 exposure. More-
over, Aβ42-induced neurodegeneration was mitigated after Tspo
depletion and male lifespan increased in diseased ﬂies, providingnovel evidence of the role of TSPO after radiation exposure and
oxidative stress [180].
Other putative links between TSPO and ROS formation involve
protoporphyrin IX (PPIX), which promotes cell death through ROS
formation in complex with TSPO [181]. Furthermore, activation of
TSPO by NO is associated with apoptosis in glioblastoma cell lines
via collapse of mitochondrial membrane potential, mitochondrial
ROS formation and DNA fragmentation, revealing a link between
TSPO-NO cytotoxicity [182]. Santoro et al. [183] recently demon-
strated that application of synthetic TSPO ligands from the N,N-
dialkyl-2-phenylindol-3-ylglyoxylamides class to C6 glioma cell
line cultures correlates with reduced lipid peroxidation and re-
ductions in iNOS and COX-2 expression in LPS-stimulated cells
[183], providing further evidence of the involvement of TSPO in
the induction of pro-inﬂammatory factors and ROS-mediated
oxidative stress. Interestingly, Choi et al. [184] found that exposure
of microglial cell cultures to prototypical TSPO ligands PK11195
and Ro5–4864 increased microglial proliferation, phagocytosis,
ROS production and cytokine release relative to vehicle controls.
Importantly, ROS production was mitigated with application of
NADPH oxidase inhibitors, suggesting an interaction between
TSPO and NADPH oxidase in the production of ROS in microglia
[54,184]. In microglia, NADPH oxidase is modulated by JNK sig-
nalling cascade which contributes to the production of ROS [60],
and importantly this has also been demonstrated subsequent to
10 Gy radiation exposure in microglial cell cultures [49]. Interest-
ingly, TSPO gene and protein expression may be also driven by
signalling pathways involving MAPK through AP-1 transcription
factors [185], revealing a putative connection between TSPO and
ROS formation that may be implicated after exposure to ionising
radiation.
Further research directed in this ﬁeld may lead to novel in-
sights into the postulated link between TPSO, ROS and neuroin-
ﬂammation in the coordination of responses to ionising radiation
(refer to Fig. 3). As there has been no real attempt in the literature
to directly characterise the response of TSPO after ionising radia-
tion, TSPO is regarded as an attractive target for further studies
and may delineate the complex pathways between
C. Betlazar et al. / Redox Biology 9 (2016) 144–156152neuroinﬂammation, ROS and antioxidant regulation, and the or-
chestration of a pro-inﬂammatory or anti-inﬂammatory responses
after high or low dose irradiation. Because of the extreme sensi-
tivity of TSPO expression to microglial activation, it is of interest to
determine and proﬁle the exact responses of microglia to ionising
radiation at different doses, facilitated by TSPO. The remaining
uncertainties surrounding neurobiological responses to ionising
radiation necessitate further investigation, and the utility of a vi-
able TSPO knockout mouse model, as well as the capacity for
in vivo neuroimaging of TSPO using high afﬁnity ligands, will fa-
cilitate new approaches to research in this ﬁeld. Not only will this
enhance understanding of the responses of the CNS to ionising
radiation, it will also clarify the enigmatic role of TSPO in cell
functioning.6. Conclusion and open questions
The complex responses of the CNS under conditions of stress or
pathology are largely underscored by neuroinﬂammation and
mitochondrial redox balance. These mechanisms also coordinate
responses to high and low dose ionising radiation. Exposure to
high doses can impact the functionality of the CNS by inducing
ROS formation, oxidative stress, alterations in DNA and gene ex-
pression, and activation of a neuroinﬂammatory response, all of
which can propagate cellular damage. Whilst there is greater un-
certainty surrounding responses to low dose irradiation, con-
siderable evidence suggests that low dose exposure can manifest
repair and protection to cells. Though there is sizeable literature
challenging the current paradigm of the linear no-threshold
model, the remaining contention and uncertainty surrounding low
dose effects necessitates further studies which directly examine
the mitochondrial mechanisms that stimulate antioxidant de-
fences, as well as directly characterising the responses of microglia
after low dose irradiation. This may also aid in investigating the
dichotomous phenotypes of microglial activation, transitioning
between M1/M2 activation states in response to low or high doses.
Due to the ‘anti-inﬂammatory’ effects of low dose irradiation, it
can be postulated that low dose ionising radiation may produce an
M2 type microglial activation, which contributes to the reparative
and protective effects that are present in many studies. This would
create a ‘non-linear differential threshold’ of microglial activation
in response to ionising radiation, transitioning between anti-in-
ﬂammatory and pro-inﬂammatory functional states.
Collectively, animal radiobiological studies on the effects of
high and low dose ionising radiation on the CNS highlight the
variability in responses. It is most likely that responses are con-
tingent not just on total dose, but dose rates, schedule of delivery
and in vitro/in vivo experimental conditions. As mentioned prior,
many studies focus on single dose irradiation schemes and mea-
sure acute cellular responses. In many cases, it has been reported
that the outcomes of single dose exposure cannot predict or ex-
tend to outcomes after fractionated delivery, which produce dis-
parate responses. Concomitantly, the effects of protracted/chronic
dose delivery over a period time have different effects on cells,
thus, further studies are needed in order to extrapolate radiation
effects as a function of how doses are delivered. This may also be
beneﬁcial for studying the different responses of microglia to
varying stimuli at varying doses and intensities, and may elucidate
the cellular mechanisms that produce radioadaptive responses
subsequent to priming with low dose irradiation.
In order to advance understanding of the mechanisms of ra-
diation responses in the CNS, biomarkers of pathology may be of
high utility moving forward in research. More comprehensive
studies that exploit the exclusive upregulation of TSPO in activated
microglia under conditions of stress in the brain will aid inexplicating the role of neuroinﬂammatory responses after ionising
radiation exposure, whilst also clarifying the exact function of
TSPO and its role in cellular functioning. As more evidence
emerges regarding the role of TSPO in modulating ROS, it may by
extension lead to new insights into the role of TSPO in co-
ordinating responses after ionising radiation that should be ad-
dressed in further studies. Furthermore, the controversial nature
of low dose irradiation in conferring neuroprotection and the
current lack of understanding of this phenomenon necessitate
further investigation which will beneﬁt from utilising TSPO, par-
ticularly its role in mitochondrial dependent processes. Future
studies that elucidate the beneﬁcial impact of low dose ionising
radiation may ultimately uncover therapeutic potential in the
prevention and treatment of sub-syndromal disorders associated
with neuroinﬂammation, or may ameliorate the deleterious effects
of neurodegenerative disorders. They may also pave the way for
different approaches to setting radiation protection standards and
regulatory bodies in making informed decisions, as well as a re-
assessment of the validity of the linear no-threshold model.Acknowledgements
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